What Is Adherence? Understanding How to Measure and Improve Medication Adherence

Medication adherence — the degree to which a patient correctly follows medical advice and takes their prescribed treatment — is one of the most important yet overlooked factors in healthcare outcomes. Poor adherence can lead to treatment failure, disease progression, avoidable hospitalizations, and increased healthcare costs. But what exactly is adherence, how can it be measured, and what tools can help clinicians and researchers evaluate it effectively?

What Is Adherence?
Medication adherence refers to the extent to which patients take their medications as prescribed — including the correct dose, timing, and frequency. The World Health Organization (WHO) describes adherence as a multidimensional behavior influenced by five key dimensions:

1. Patient-related factors (beliefs, motivation, forgetfulness)
2. Therapy-related factors (complexity, side effects)
3. Condition-related factors (chronicity, symptom burden)
4. Healthcare system factors (access, provider communication)
5. Socioeconomic factors (cost, support, education)

Measuring adherence accurately is crucial not only for evaluating treatment effectiveness but also for identifying barriers that can be addressed through tailored interventions.

Tools to Measure Medication Adherence
There are numerous methods to assess adherence, ranging from subjective self-reports to objective monitoring:

• Pharmacy refill records – Track how often prescriptions are refilled.
• Pill counts – Compare the number of pills taken versus prescribed.
• Electronic monitoring devices – Use smart caps or apps to log medication use.
• Biological measures – Detect medication levels in blood or urine.
• Self-report questionnaires – Quick, low-cost tools that measure adherence behavior or confidence.

Each tool has advantages and limitations. For instance, electronic monitoring provides detailed data but can be costly, while self-report scales are inexpensive and easy to administer but rely on honest and accurate reporting.

Lagging vs. Leading Metrics in Adherence Measurement
In quality improvement and behavior analysis, metrics are often categorized as lagging or leading:

• Lagging metrics measure outcomes — what happened after the behavior occurred.
• Leading metrics measure predictors — what behaviors or attitudes influence future outcomes.

In medication adherence research, both types of metrics are valuable. Understanding the difference can help clinicians design better adherence improvement strategies.

The Morisky Scales: A Lagging Adherence Metric
The Morisky Medication Adherence Scales (MMAS-4 and MMAS-8) are among the most widely used and validated self-report tools for assessing medication adherence. Developed by Dr. Donald E. Morisky, the MMAS identifies behaviors that reflect past adherence patterns — such as forgetting doses, stopping medication when feeling better, or being careless at times.

Why the MMAS is a lagging indicator:

• It measures what has already occurred (past medication-taking behavior).
• It provides a snapshot of adherence outcomes, not future intent.
• It helps identify which behaviors led to poor adherence, guiding corrective action.

Researchers and clinicians use the MMAS to evaluate adherence outcomes in populations, assess the effectiveness of interventions, and predict health outcomes such as blood pressure control or glycemic stability.
The SEAMS: A Leading Adherence Metric
The Self-Efficacy for Appropriate Medication Use Scale (SEAMS) measures a patient’s confidence in their ability to take medications correctly under various circumstances — for example, when traveling, feeling ill, or having a busy day.
Why the SEAMS is a leading indicator:

• It measures predictive behavior, not just past performance.
• Higher self-efficacy often leads to improved future adherence.
• It helps clinicians identify motivational and educational needs before problems arise.

By assessing confidence rather than behavior, the SEAMS offers a forward-looking measure that can help healthcare teams target early interventions and empower patients.

Using Both Metrics Together
The most effective adherence programs combine both lagging and leading measures:

• MMAS (Lagging): Identifies what happened — missed doses, nonadherence patterns, reasons for lapses.
• SEAMS (Leading): Predicts what is likely to happen — confidence, readiness, and barriers to consistent adherence.

When used together, these tools provide a comprehensive understanding of adherence, guiding tailored interventions that both address past issues and strengthen future adherence behaviors.








​


​






​